A Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Tolerability of Milnacipran 100mg/day in the Management of Fibromyalgia

被引：0
|
作者：
Arnold, Lesley [1 ]
Gendreau, R. Michael [1 ]
Spera, Allan [1 ]
Gendreau, Judy [1 ]
Wang, Yong [1 ]
机构：
[1] Univ Cincinnati, Cincinnati, OH 45221 USA
来源：
JOURNAL OF WOMENS HEALTH | 2010年 / 19卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
06
引用
收藏
页码：605 / 605
页数：1
相关论文
共 50 条
  • [31] EFFICACY OF TAMSULOSIN IN THE MANAGEMENT OF LOWER URETERAL STONES: A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY OF 100 PATIENTS
    Alobaidy, Abdulqadir Dawood
    Al Ansari, Abdulla
    Al Naimi, Abdulla
    Assadiq, Khalid
    Azmi, Mohamed
    Shokeir, Ahmed
    JOURNAL OF ENDOUROLOGY, 2012, 26 : A326 - A327
  • [32] Efficacy of ozone therapy as an add-on treatment in fibromyalgia: A randomized double-blind placebo-controlled study
    Sucuoglu, Hamza
    Soydas, Nalan
    JOURNAL OF BACK AND MUSCULOSKELETAL REHABILITATION, 2023, 36 (02) : 357 - 366
  • [33] The efficacy and safety of milnacipran for treatment of fibromyalgia. A randomized, double-blind, placebo-controlled trial (vol 36, pg 398, 2009)
    Mease, P. J.
    Clauw, D. J.
    Gendreau, R. M.
    JOURNAL OF RHEUMATOLOGY, 2009, 36 (03) : 661 - 661
  • [34] Tolerability and Efficacy of Customized IncobotulinumtoxinA Injections for Essential Tremor: A Randomized, Double-Blind, Placebo-Controlled Study
    Jog, Mandar
    Lee, Jack
    Scheschonka, Astrid
    Chen, Robert
    Ismail, Farooq
    Boulias, Chris
    Hobson, Douglas
    King, David
    Althaus, Michael
    Simon, Olivier
    Dersch, Hanna
    Frucht, Steven
    Simpson, David M.
    TOXINS, 2020, 12 (12)
  • [35] A randomized, double-blind, placebo-controlled study of the efficacy and tolerability of policosanol in adolescents with type II hypercholesterolemia
    Castaño, G
    Más, R
    Fernández, L
    Illnait, J
    Hernández, E
    Fernández, JC
    Gámez, R
    Gutiérrez, C
    Alvarez, E
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2002, 63 (04): : 286 - 303
  • [36] A randomized, double-blind, placebo-controlled trial: Paroxetine controlled release in fibromyalgia
    Patkar, AA
    Masand, PS
    Jiang, W
    Krulewicz, S
    Dube, E
    Purcell, C
    McMorran, C
    Peindl, K
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2004, 14 : S319 - S320
  • [37] Creatine Supplementation in Fibromyalgia: A Randomized, Double-Blind, Placebo-Controlled Trial
    Alves, Christiano R. R.
    Santiago, Bianca M.
    Lima, Fernanda R.
    Otaduy, Maria C. G.
    Calich, Ana Luisa
    Tritto, Aline C. C.
    de Sa Pinto, Ana Lucia
    Roschel, Hamilton
    Leite, Claudia C.
    Benatti, Fabiana B.
    Bonfa, Eloisa
    Gualano, Bruno
    ARTHRITIS CARE & RESEARCH, 2013, 65 (09) : 1449 - 1459
  • [38] Efficacy and tolerability of estradiol 1 mg and drospirenone 2 mg in postmenopausal Korean women: A double-blind, randomized, placebo-controlled, multicenter study
    Lee, B. S.
    Kang, B. M.
    Yoon, B. K.
    Choi, H.
    Park, H. M.
    Kim, J. G.
    MATURITAS, 2007, 57 (04) : 361 - 369
  • [39] Dual Reuptake Inhibitor Milnacipran and Spinal Pain Pathways in Fibromyalgia Patients: A Randomized, Double-Blind, Placebo-Controlled Trial
    Matthey, Alain
    Cedraschi, Christine
    Piguet, Valerie
    Besson, Marie
    Chabert, Jocelyne
    Daali, Youssef
    Courvoisier, Delphine
    Montagne, Agnes
    Dayer, Pierre
    Desmeules, Jules
    PAIN PHYSICIAN, 2013, 16 (05) : E553 - E562
  • [40] Worsening of Fibromyalgia Symptoms Following Abrupt Discontinuation of Milnacipran: Results from a Randomized, Double-Blind, Placebo-Controlled Trial
    Saxe, Philippe A.
    Arnold, Lesley M.
    Gendreau, R. Michael
    Spera, Allan
    Gendreau, Judy
    Wang, Yong
    NEUROLOGY, 2010, 74 (09) : A187 - A187
12345